Abstract
BackgroundIntake of lutein and zeaxanthin (L+Z) may reduce age‐related macular degeneration (AMD) risk. Plasma L+Z, which reflects short‐term intake, is often used to assess status. Red blood cell (RBC) level may reflect long‐term intake. Use of RBC to assess status has not been explored. Macular pigment (L+Z in retinal tissue) is considered reflective of long‐term L+Z status. Evaluation of relationships of L+Z in plasma and RBC with macular pigment density (MPD) may be useful.ObjectiveTo determine the relationship between L+Z in plasma and RBC with MPD.MethodsBlood and MPD were obtained from 15 healthy adults. Extraction and measure of L+Z in plasma and RBC were performed with standard lipid extraction methods and reverse‐phase, gradient HPLC. MPD was measured with a psychophysical method at a 1‐deg target and a 7‐deg parafoveal reference. Pearson correlation coefficients were used to measure relationships with MPD.ResultsPlasma and RBC levels of L+Z were significantly related to MPD (p = 0.050 and 0.018, respectively). The correlation was greater for RBC than plasma (r = 0.622 and 0.532, respectively).ConclusionsA greater correlation of RBC L+Z with MPD may be due to RBC and MPD reflecting long‐term intake and plasma reflecting short‐term intake. Measures of L+Z in RBC in studies examining the relationship between L+Z status and AMD may be useful. Support: USDA grant# 58‐1950‐7‐707
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.